CVS Caremark Corp. (CVS) Releases Q1 Earnings Guidance
CVS Caremark Corp. (NYSE:CVS) updated its first quarter earnings guidance on Tuesday. The company provided EPS guidance of $1.03-1.06 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.97, AnalystRatingsNetwork reports. CVS Caremark Corp. also updated its FY14 guidance to $4.36-4.50 EPS.
Several analysts have recently commented on the stock. Analysts at ISI Group upgraded shares of CVS Caremark Corp. from a buy rating to a strong-buy rating in a research note on Wednesday, January 22nd. They now have a $78.50 price target on the stock. On a related note, analysts at Leerink Swann initiated coverage on shares of CVS Caremark Corp. in a research note on Thursday, January 9th. They set an outperform rating and a $85.00 price target on the stock. Finally, analysts at Deutsche Bank reiterated a hold rating on shares of CVS Caremark Corp. in a research note on Friday, December 20th. They now have a $76.00 price target on the stock, up previously from $71.00. Seven equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the company. CVS Caremark Corp. currently has a consensus rating of Buy and an average price target of $73.80.
CVS Caremark Corp. (NYSE:CVS) opened at 66.94 on Tuesday. CVS Caremark Corp. has a 52 week low of $50.21 and a 52 week high of $71.99. The stock’s 50-day moving average is $68.70 and its 200-day moving average is $63.34. The company has a market cap of $80.596 billion and a P/E ratio of 18.65.
CVS Caremark Corp. (NYSE:CVS) last issued its quarterly earnings data on Tuesday, February 11th. The company reported $1.12 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.11 by $0.01. The company had revenue of $32.80 million for the quarter, compared to the consensus estimate of $32.67 million. During the same quarter last year, the company posted $1.14 earnings per share. CVS Caremark Corp.’s revenue was up 4.6% compared to the same quarter last year. Analysts expect that CVS Caremark Corp. will post $3.96 EPS for the current fiscal year.
CVS Caremark Corporation (NYSE:CVS), together with its subsidiaries, is a pharmacy health care provider in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.